Primary graft dysfunction attenuates improvements in health-related quality of life after lung transplantation, but not disability or depression
- PMID: 32794295
- DOI: 10.1111/ajt.16257
Primary graft dysfunction attenuates improvements in health-related quality of life after lung transplantation, but not disability or depression
Abstract
Disability, depressive symptoms, and impaired health-related quality of life (HRQL) are common among patients with life-threatening respiratory compromise. We sought to determine if primary graft dysfunction (PGD), a syndrome of acute lung injury, attenuates improvements in patient-reported outcomes after transplantation. In a single-center prospective cohort, we assessed disability, depressive symptoms, and HRQL before and at 3- to 6-month intervals after lung transplantation. We estimated the magnitude of change in disability, depressive symptoms, and HRQL with hierarchical segmented linear mixed-effects models. Among 251 lung transplant recipients, 50 developed PGD Grade 3. Regardless of PGD severity, participants had improvements in disability and depressive symptoms, as well as generic-physical, generic-mental, respiratory-specific, and health-utility HRQL, exceeding 1- to 4-fold the minimally clinically important difference across all instruments. Participants with PGD Grade 3 had a lower magnitude of improvement in generic-physical HRQL and health-utility than in all other participants. Among participants with PGD Grade 3, prolonged mechanical ventilation was associated with greater attenuation of improvements. PGD remains a threat to the 2 primary aims of lung transplantation, extending survival and improving HRQL. Attenuation of improvement persists long after hospital discharge. Future studies should assess if interventions can mitigate the impact of PGD on patient-reported outcomes.
Keywords: clinical research/practice; depression; lung transplantation/pulmonology; primary nonfunction; quality of life (QOL); rehabilitation.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.
Comment in
-
Primary graft dysfunction and health-related quality of life after transplantation: The good, the bad, and the missing.Am J Transplant. 2021 Feb;21(2):456-457. doi: 10.1111/ajt.16313. Epub 2020 Oct 2. Am J Transplant. 2021. PMID: 32957167 No abstract available.
References
REFERENCES
-
- Kolaitis NA, Singer JP. Defining success in lung transplantation: from survival to quality of life. Semin Respir Crit Care Med. 2018;39(2):255-268.
-
- Singer JP, Katz PP, Soong A, et al. Effect of lung transplantation on health-related quality of life in the era of the lung allocation score: a U.S. prospective cohort study. Am J Transplant. 2017;17(5):1334-1345.
-
- Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014-an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015;34(1):1-15.
-
- Kolaitis NA, Soong A, Shrestha P, et al. Improvement in patient-reported outcomes after lung transplantation is not impacted by the use of extracorporeal membrane oxygenation as a bridge to transplantation. J Thorac Cardiovasc Surg. 2018;156(1):440-448 e442.
-
- Singer LG, Chowdhury NA, Faughnan ME, et al. Effects of recipient age and diagnosis on health-related quality-of-life benefit of lung transplantation. Am J Respir Crit Care Med. 2015;192(8):965-973.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
